Currently, there are 85.31M common shares owned by the public and among those 82.87M shares have been available to trade.
The company’s stock has a 5-day price change of -29.70% and -30.34% over the past three months. JELD shares are trading -47.46% year to date (YTD), with the 12-month market performance down to -21.64% lower. It has a 12-month low price of $12.29 and touched a high of $21.75 over the same period. JELD has an average intraday trading volume of 509.56K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -32.01%, -32.92%, and -39.24% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of JELD-WEN Holding Inc (NYSE: JELD) shares accounts for 96.93% of the company’s 85.31M shares outstanding.
It has a market capitalization of $838.66M and a beta (3y monthly) value of 2.22. The earnings-per-share (ttm) stands at -$1.69. Price movements for the stock have been influenced by the stock’s volatility, which stands at 6.97% over the week and 3.75% over the month.
Earnings per share for the fiscal year are expected to decrease by -18.56%, and 21.35% over the next financial year. EPS should grow at an annualized rate of -7.00% over the next five years, compared to -16.41% over the past 5-year period.
Looking at the support for the JELD, a number of firms have released research notes about the stock. Loop Capital stated their Hold rating for the stock in a research note on February 15, 2024, with the firm’s price target at $22. JP Morgan was of a view on December 20, 2022 that the stock is Neutral, while Wolfe Research gave the stock Underperform rating on November 08, 2022, issuing a price target of $7. Credit Suisse on their part issued Neutral rating on October 14, 2022.
